Dabur India Limited (DABUR.BO)
INR 503.0
(-0.47%)
INR 503.0
(-0.47%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 48.19 Billion INR | 14.4% |
| 2022 | 42.12 Billion INR | 9.07% |
| 2021 | 38.62 Billion INR | 22.75% |
| 2020 | 31.46 Billion INR | 16.05% |
| 2019 | 27.11 Billion INR | -2.23% |
| 2018 | 27.73 Billion INR | -6.57% |
| 2017 | 29.68 Billion INR | 3.79% |
| 2016 | 28.6 Billion INR | 4.38% |
| 2015 | 27.39 Billion INR | 5.59% |
| 2014 | 25.94 Billion INR | -1.71% |
| 2013 | 26.4 Billion INR | 1.49% |
| 2012 | 26.01 Billion INR | 4.88% |
| 2011 | 24.8 Billion INR | -1.88% |
| 2010 | 25.27 Billion INR | 146.24% |
| 2009 | 10.26 Billion INR | 9.72% |
| 2008 | 9.35 Billion INR | 25.12% |
| 2007 | 7.47 Billion INR | 19.68% |
| 2006 | 6.24 Billion INR | 12.06% |
| 2005 | 5.57 Billion INR | -1.03% |
| 2004 | 5.63 Billion INR | 32.13% |
| 2003 | 4.26 Billion INR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | -103.03 Billion INR | -313.77% |
| 2024 Q2 | 55.87 Billion INR | 154.23% |
| 2023 Q4 | 48.19 Billion INR | 0.0% |
| 2023 Q2 | 48.27 Billion INR | 0.0% |
| 2023 FY | 48.19 Billion INR | 14.4% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q1 | - INR | -100.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q4 | 42.12 Billion INR | 0.0% |
| 2022 FY | 42.12 Billion INR | 9.07% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q2 | 38.95 Billion INR | 0.0% |
| 2021 FY | 38.62 Billion INR | 22.75% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q2 | 34.79 Billion INR | 0.0% |
| 2021 Q4 | 38.62 Billion INR | 0.0% |
| 2020 Q4 | 31.46 Billion INR | 0.0% |
| 2020 Q2 | 31.1 Billion INR | 0.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 FY | 31.46 Billion INR | 16.05% |
| 2020 Q1 | - INR | -100.0% |
| 2019 Q1 | - INR | -100.0% |
| 2019 Q4 | 27.11 Billion INR | 0.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 FY | 27.11 Billion INR | -2.23% |
| 2019 Q2 | 29.08 Billion INR | 0.0% |
| 2018 Q1 | - INR | -100.0% |
| 2018 FY | 27.73 Billion INR | -6.57% |
| 2018 Q4 | 27.73 Billion INR | 0.0% |
| 2018 Q3 | - INR | -100.0% |
| 2018 Q2 | 29.79 Billion INR | 0.0% |
| 2017 Q4 | 29.68 Billion INR | 0.0% |
| 2017 Q2 | 28.03 Billion INR | 0.0% |
| 2017 FY | 29.68 Billion INR | 3.79% |
| 2017 Q3 | - INR | -100.0% |
| 2017 Q1 | - INR | -100.0% |
| 2016 Q4 | 28.6 Billion INR | 0.0% |
| 2016 Q2 | 29.42 Billion INR | 0.0% |
| 2016 Q3 | - INR | -100.0% |
| 2016 FY | 28.6 Billion INR | 4.38% |
| 2016 Q1 | - INR | -100.0% |
| 2015 Q2 | 30.55 Billion INR | 0.0% |
| 2015 Q4 | 27.39 Billion INR | 0.0% |
| 2015 Q1 | - INR | -100.0% |
| 2015 FY | 27.39 Billion INR | 5.59% |
| 2015 Q3 | - INR | -100.0% |
| 2014 Q4 | 25.94 Billion INR | 0.0% |
| 2014 Q2 | 23.42 Billion INR | 0.0% |
| 2014 Q1 | - INR | -100.0% |
| 2014 FY | 25.94 Billion INR | -1.71% |
| 2014 Q3 | - INR | -100.0% |
| 2013 FY | 26.4 Billion INR | 1.49% |
| 2013 Q1 | - INR | -100.0% |
| 2013 Q2 | 27.65 Billion INR | 0.0% |
| 2013 Q3 | - INR | -100.0% |
| 2013 Q4 | 26.4 Billion INR | 0.0% |
| 2012 Q4 | 26.01 Billion INR | 0.0% |
| 2012 FY | 26.01 Billion INR | 4.88% |
| 2011 FY | 24.8 Billion INR | -1.88% |
| 2011 Q4 | 24.8 Billion INR | 0.0% |
| 2010 FY | 25.27 Billion INR | 146.24% |
| 2009 FY | 10.26 Billion INR | 9.72% |
| 2008 FY | 9.35 Billion INR | 25.12% |
| 2007 FY | 7.47 Billion INR | 19.68% |
| 2006 FY | 6.24 Billion INR | 12.06% |
| 2005 FY | 5.57 Billion INR | -1.03% |
| 2004 FY | 5.63 Billion INR | 32.13% |
| 2003 FY | 4.26 Billion INR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Ador Multiproducts Limited | 28.52 Million INR | -168842.793% |
| Ambica Agarbathies Aroma & Industries Limited | 1.09 Billion INR | -4282.243% |
| Bajaj Consumer Care Limited | 1.53 Billion INR | -3050.043% |
| Colgate-Palmolive (India) Limited | 13.22 Billion INR | -264.522% |
| Cupid Limited | 186.52 Million INR | -25738.757% |
| Emami Limited | 8.21 Billion INR | -486.333% |
| Gillette India Limited | 8.59 Billion INR | -460.758% |
| Godrej Consumer Products Limited | 58.97 Billion INR | 18.275% |
| Hindustan Unilever Limited | 270.76 Billion INR | 82.2% |
| Hipolin Limited | 48.57 Million INR | -99123.849% |
| Honasa Consumer Limited | 5.36 Billion INR | -797.884% |
| JHS Svendgaard Laboratories Limited | 271.7 Million INR | -17638.291% |
| Jyothy Labs Limited | 5.9 Billion INR | -715.886% |
| Kaya Limited | 5.22 Billion INR | -822.873% |
| Marico Limited | 32.52 Billion INR | -48.204% |
| N.K Industries Limited | 22.4 Billion INR | -115.133% |
| PAOS INDUSTRIES LIMITED | 163.96 Million INR | -29293.361% |
| Paramount Cosmetics (India) Limited | 205.72 Million INR | -23327.391% |
| Pee Cee Cosma Sope Limited | 80.17 Million INR | -60010.503% |
| Procter & Gamble Hygiene and Health Care Limited | 10.83 Billion INR | -344.736% |